ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

T Cell Repertoire Diversity in HCV-Associated Hepatocellular Carcinoma Patients Waitlisted for Liver Transplantation and Receiving Liver-Directed Therapy

K. Nunez, T. Sandow, A. Cohen, P. Thevenot

Ochsner Health, New Orleans, LA

Meeting: 2021 American Transplant Congress

Abstract number: 87

Keywords: Hepatitis C, Hepatocellular carcinoma, Lymphocyte activation, T cell receptors (TcR)

Topic: Clinical Science » Liver » Liver: Hepatocellular Carcinoma and Other Malignancies

Session Information

Session Name: Liver Transplant Oncology

Session Type: Rapid Fire Oral Abstract

Date: Saturday, June 5, 2021

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:20pm-6:25pm

Location: Virtual

*Purpose: T cell receptor (TCR) sequencing in hepatocellular carcinoma (HCC) patients revealed a diverse TCR repertoire in hepatitis B-associated HCC-infiltrating T cells. In this study, we investigate changes in TCR diversity in both viremic and nonviremic hepatitis C-associated HCC (HCV-HCC) patients following liver-directed therapy (LDT) and links to bridge to transplant waitlist outcome.

*Methods: HCV-HCC patients receiving LDT as a bridge to liver transplantation were prospectively enrolled at a high-volume transplant center. Peripheral blood T cells were characterized by flow cytometry at baseline and treatment follow-up as well as longitudinally while on the waitlist. T cell DNA isolated at each time point was sequenced and analyzed using ImmunoSeq Analyzer (Adaptive Biotechnologies). Response to LDT was assessed by mRECIST.

*Results: The cohort (n=17) was stratified based on HCV status (viremic n=10 and nonviremic n=7). Only 3 TCR clonotypes were shared over the entire cohort. Viremic HCV was associated with a more diverse T cell repertoire prior to and following LDT (P=0.007 and P=0.032). LDT resulted in a treatment-dependent increase in TCR diversity (P=0.034) and unique TCR clonotypes at follow-up independent of response to LDT. TCR diversity was strongly correlated with T cell senescence (CD57) as well as the PD-1 checkpoint inhibitor pathway in both CD4 (P=0.009 and P=0.037) and CD8 T cells (P=0.016 and P=0.019), respectively. Low TCR diversity following LDT was also associated with waitlist tumor progression (P=0.015). In patients successfully bridged to liver transplantation, 2.3-10.4% of intratumoral T cell clonotypes found in explant tumors were also found in circulating T cells prior to LDT. The percentage of clonotype overlap between TILs and circulating T cells did not change following treatment.

*Conclusions: The TCR repertoire is diverse in HCV-HCC patients and shifted based on viremic HCV status and LDT. HCV-HCC patients with low TCR diversity following treatment are at greater risk of tumor progression which may be mediated by T cell senescence and checkpoint inhibitory pathways. Longitudinal TCR profiling may uncover unique HCC biology or treatment pathways linked to effective neoantigen responses and improved bridge to transplant outcomes.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Nunez K, Sandow T, Cohen A, Thevenot P. T Cell Repertoire Diversity in HCV-Associated Hepatocellular Carcinoma Patients Waitlisted for Liver Transplantation and Receiving Liver-Directed Therapy [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/t-cell-repertoire-diversity-in-hcv-associated-hepatocellular-carcinoma-patients-waitlisted-for-liver-transplantation-and-receiving-liver-directed-therapy/. Accessed May 9, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences